Search Results 921-930 of 13342 for monoclonal antibody

1. New antibody test for MS diagnosis - Mayo Clinic

   Mayo Clinic has identified an immunoglobulin kappa value comparable to the detection of oligoclonal bands for the diagnosis of MS. The antibody test is more ...

2. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

   A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

3. Triple-Negative Breast Cancer (TNBC) Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ruxolitinib phosphate may stop the growth of ...

4. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

5. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID) - Mayo Clinic

   ... monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 months. ... antibodies to hepatitis B core antigen [anti-HBc] and/or ...

6. Medication overuse headaches - Diagnosis and treatment - Mayo Clinic

   If you have a history of migraine, your healthcare professional might suggest a CGRP monoclonal antibody such as erenumab (Aimovig), galcanezumab (Emgality) ...

7. Fallopian Tube Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Using an Avatar, a living tumor sample with ...

8. Mayo Clinic clinical trials in patients with tumor-induced osteomalacia

   An FGF23 monoclonal antibody (burosumab) was recently approved by the U.S. Food and Drug Administration for use in patients in whom surgical tumor resection ...

9. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

   A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

10. Publications - Sarosh R. Irani, B.M., B.Ch., D.Phil. - Mayo Clinic

    Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo. ... Magnetic Resonance Imaging Characteristics of LGI1-Antibody and ...